The Fibrin Patch Soft Tissue Study

PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
Hemostasis
Interventions
DRUG

Fibrin Pad

Fibrin Patch is a sterile bio-absorbable combination product consisting of two constituent parts- a flexible matrix and a coating of two biological components (Human Fibrinogen and Human Thrombin).

DEVICE

SURGICEL™

Absorbable hemostat

Trial Locations (11)

11040

Long Island Jewish Medical Center, New Hyde Park

18103

Lehigh Valley Hospital, Allentown

21201

University of Maryland Medical Center, Baltimore

21229

St. Agnes Healthcare, Inc., Baltimore

30322

Emory University Hospital, Atlanta

30912

Medical College of Georgia, Augusta

32216

Jacksonville Center for Clinical Research, Jacksonville

33173

Baptist Hosptial, Miami

35294

University of Alabama, Birmingham

77030

The University of Texas MD Anderson Cancer Center, Houston

Weill Medical Colleges of Cornell University - Methodist Hospital, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

OMRIX Biopharmaceuticals

INDUSTRY

lead

Ethicon, Inc.

INDUSTRY

NCT00658723 - The Fibrin Patch Soft Tissue Study | Biotech Hunter | Biotech Hunter